Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Leukemia, Myeloid, Acute 13Myelodysplastic Syndromes 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Myeloproliferative Disorders 6Leukemia, Myelomonocytic, Chronic 6Congenital Abnormalities 5Lymphoma, Non-Hodgkin 4Leukemia, Myeloid, Accelerated Phase 4Leukemia 4Blast Crisis 4Anemia, Refractory, with Excess of Blasts 4Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Leukemia, Promyelocytic, Acute 3Leukemia, Myeloid, Chronic-Phase 3Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3Leukemia, Megakaryoblastic, Acute 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia, Erythroblastic, Acute 3Hodgkin Disease 3Thrombocythemia, Essential 2Prostatic Neoplasms 2Primary Myelofibrosis 2Polycythemia Vera 2Multiple Myeloma 2Lymphoma, Mantle-Cell 2Leukemia, Myelomonocytic, Acute 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia, Monocytic, Acute 2Leukemia, Hairy Cell 2

Interventions

imetelstat 1Vorinostat 1Spectroscopy, Near-Infrared 1Phlebotomy 1N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide 1Hydroxyurea 1Histone Deacetylase Inhibitors 1GRN163L peptide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Polycythemia × Vorinostat × Myeloid × Clear all
NCT00866762 2011-12-12

A Study of the Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia

Copenhagen University Hospital at Herlev

Phase 2 Unknown
60 enrolled
Myeloid

Hematologic Diseases, Polycythemia, Polycythemia Vera, Thrombocythemia, Essential

Data powered by HemOnc (CC BY 4.0) Colophon âš¡